A Q&A with ‘Rising Leader’ Therese Liechtenstein
Therese was selected as one of the top 30 Rising Leaders in the 3rd annual listing of In Vivo’s ‘Rising Leaders’ 2022.
Tag Archive for: VC
Novo Seeds Provides Business Update on a Record Year – Building Exceptional Companies for Global Impact
Over US$ 550 million raised by portfolio companies in 2021 IO Biotech IPO on US NASDAQ Forendo Pharma acquired for nearly US$ 1 billion Muna launched with world-leading science to advance latest scientific breakthroughs in neuroscience Adcendo raised US$ 60 million Series A to deliver next-generation Antibody-Drug Conjugates Hemab raised US$ 50 million Series A to […]
Anglonordic Life Science Conference
4-5 MAY 2022 | LONDON
VC Investor Panel: Building the Future Champions
Watch a replay of the live session here or read our top takeaways below…
How close are we to a COVID-19 cure? A biotech VC perspective
“A viable therapeutic would dramatically change the tone of the COVID-19 pandemic, giving hope and a path to eradicating the virus, saving lives and livelihoods.”
